Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by José López Torrecilla
Uroncor Consensus Statement: Management of Biochemical Recurrence After Radical Radiotherapy for Prostate Cancer: From Biochemical Failure to Castration Resistance
Reports of Practical Oncology and Radiotherapy
Cancer Research
Oncology
Radiology
Nuclear Medicine
Imaging
SIMBOSPROST: Prevalence of Metabolic Syndrome and Osteoporosis in Prostate Cancer Patients Treated With Radiotherapy and Androgen Deprivation Therapy: A Multicentre, Cross-Sectional Study
Reports of Practical Oncology and Radiotherapy
Cancer Research
Oncology
Radiology
Nuclear Medicine
Imaging
Related publications
Management of Biochemical Recurrence After Primary Localized Therapy for Prostate Cancer
Frontiers in Oncology
Cancer Research
Oncology
Prostate Cancer Biochemical Recurrence Rates After Robotic-Assisted Laparoscopic Radical Prostatectomy
Journal of the Society of Laparoendoscopic Surgeons
Surgery
Pathological Features of Lymph Node Metastasis for Predicting Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
Journal of Urology
Urology
Impact of Biochemical Failure on Long-Term Clinical Outcome After Radical Prostatectomy for Prostate Cancer in Japan
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
A Tri-Marker Proliferation Index Predicts Biochemical Recurrence After Surgery for Prostate Cancer
PLoS ONE
Multidisciplinary
Aetiology and Management of Earlier vs Later Biochemical Recurrence After Retropubic Radical Prostatectomy
BJU International
Urology
Preoperative Glycemic Control Status as a Significant Predictor of Biochemical Recurrence in Prostate Cancer Patients After Radical Prostatectomy
PLoS ONE
Multidisciplinary
Combining the Prostate Cancer Risk Index (PRIX) With the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure After Radical Prostatectomy for Prostate Cancer
Asian Pacific Journal of Cancer Prevention
Dutasteride Treatment Over 2 Years Delays Prostate-Specific Antigen Progression in Patients With Biochemical Failure After Radical Therapy for Prostate Cancer: Results From the Randomised, Placebo-Controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS)
European Urology
Urology
